Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoproliferative Disorders × obinutuzumab × 30 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma, Non-Hodgkin 6 Lymphoma 6 Recurrence 5 Lymphoma, Follicular 5 Lymphoma, B-Cell 4 Neoplasms 3 Lymphoma, Mantle-Cell 2 Mature B-Cell Malignancies 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphatic Diseases 1 Leukemia, Hairy Cell 1 Leukemia, B-Cell 1 Heart Failure 1 Cytokine Release Syndrome 1 Burkitt Lymphoma 1

Interventions

Rituximab 3 Vincristine 2 Prednisone 2 Doxorubicin 2 Cyclophosphamide 2 venetoclax 1 liposomal doxorubicin 1 ibrutinib 1 acalabrutinib 1 Zidovudine 1 Valganciclovir 1 Sirolimus 1 Nivolumab 1 Interferon-alpha 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 CA-4948 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡